Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation.

Clinical and experimental medicine - 1 Dec 2001

Sözmen E Y, Sözmen B, Girgin F K, Delen Y, Azarsiz E, Erdener D, Ersöz B

Abstract excerpt

Oxidative modification of low-density lipoprotein in the artery wall plays a crucial role in the development of atherosclerosis. This physiopathological mechanism is clearly inhibited by high-density lipoprotein possibly via paraoxonase enzyme activity, present in high-density lipoprotein. In this study, we determined the in vitro susceptibility of low-density lipoprotein to oxidation and the effect of various...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antioxidants
Share to Aryldialkylphosphatase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Catalase

Share to Cholesterol

Share to Esterases

Share to Lipoproteins, LDL

Share to Superoxide Dismutase

Share to Thiobarbituric Acid Reactive Substances

Source

Identifiers

PMID: 11918278
DOI: 10.1007/s102380100003

Genes

PON1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation.PMID 11918278Read ↗

PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.Semantic proximity Read ↗

Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme.Semantic proximity Read ↗

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.Semantic proximity Read ↗

Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.Semantic proximity Read ↗

Genetic polymorphisms of paraoxonase 1 and susceptibility to atherogenesis.Semantic proximity Read ↗

Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-->R genetic polymorphism.Semantic proximity Read ↗

Genetic markers of oxidative stress and coronary atherosclerosis.Semantic proximity Read ↗

Modulation of the antioxidant enzyme paraoxonase-1 for protection against cardiovascular diseases.Semantic proximity Read ↗

Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.Semantic proximity Read ↗

Paraoxonase gene polymorphisms, oxidative stress, and diseases.Semantic proximity Read ↗

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.Semantic proximity Read ↗

Genetic associations and serum paraoxonase levels with atherosclerosis in western Iranian patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.